The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Melkozerova O.A.

Ural'skiĭ nauchno-issledovatel'skiĭ institut okhrany materinstva i mladenchestva, Ekaterinburg

Bashmakova N.V.

Ural Scientific Research Institute of Maternity and Child Health Ministry of the Russian Federation, Yekaterinburg, Russia

Shchedrina I.D.

Ural Research Institute of Maternal and Infant Care, Ministry of Health of Russia, Yekaterinburg, Russia

Endometrial stem cells: the clinical application (a review)

Authors:

Melkozerova O.A., Bashmakova N.V., Shchedrina I.D.

More about the authors

Journal: Russian Journal of Human Reproduction. 2018;24(5): 63‑71

Read: 3329 times


To cite this article:

Melkozerova OA, Bashmakova NV, Shchedrina ID. Endometrial stem cells: the clinical application (a review). Russian Journal of Human Reproduction. 2018;24(5):63‑71. (In Russ.)
https://doi.org/10.17116/repro20182405163

Recommended articles:
The Pate­rnity Test. Russian Journal of Human Reproduction. 2025;(4):41-45
The role of pelvic inflammatory diseases in reproductive function diso­rders in women. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):48-54

References:

  1. Zdanovskiy VM, Buravchenko NB. Results of the use of assisted reproductive technologies in infertile patients with endometrial pathology. Rossijskij vestnik akushera-ginekologa. 2010;10(2):39-42. (In Russ.)
  2. Kuznetsova IV, Zemlina NS, Rashidov TN, Kovalenko MA. The problem of a thin endometrium and possible ways of its solution. Akusherstvo i ginekologiya. 2015;1(5):42-49. (In Russ.)
  3. Novikova PV, Gzgzyan AM, Niaouri DA, Dzhemlikhanova LKh, Domnina AP. Possibilities of cellular therapy in the treatment of Asherman’s syndrome. Tsitologiya. 2017;59(6):405-409. (In Russ.)
  4. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk F, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation. 1974;17(4):331-340.
  5. Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the first 10 years. Human Reproduction Update. 2016;22(2):137-163. https://doi.org/10.1093/humupd/dmv051
  6. Spencer TE, Hayashi K, Hu J, Carpenter KD. Comparative developmental biology of the mammalian uterus. Current Topics in Developmental Biology. 2005;68:85-122. https://doi.org/10.1016/S0070-2153(05)68004-0
  7. Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocrine Reviews. 2006;27(1):17-46. https://doi.org/10.1210/er.2004-0021
  8. Gargett CE, Ye L. Endometrial reconstruction from stem cells. Fertility and Sterility. 2012;98(1):11-20. https://doi.org/10.1016/j.fertnstert.2012.05.004
  9. Gargett CE, Nguyen HP, Ye L. Endometrial regeneration and endometrial stem/progenitor cells. Reviews in Endocrine and Metabolic Disorders. 2012;13(4):235-251. https://doi.org/10.1007/s11154-012-9221-9
  10. Gargett CE. Uterine stem cells: what is the evidence? Human Reproduction Update. 2007;13(1):87-101. https://doi.org/10.1093/humupd/dml045
  11. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biology of Reproduction. 2004;70(6):1738-1750. https://doi.org/10.1095/biolreprod.103.024109
  12. Schwab KE, Chan RW, Gargett CE. Putative stem cell activity of human endometrial epithelial and stromal cells during the menstrual cycle. Fertility and Sterility. 2005;84(2):1124-1130. https://doi.org/10.1016/j.fertnstert.2005.02.056
  13. Wright AJ, Andrews PW. Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Research. 2009;3(1):3-11. https://doi.org/10.1016/j.scr.2009.04.001
  14. Valentijn AJ, Palial K, Al-Lamee H, Tempest N, Drury J, Von Zglinicki T, Saretzki G, Murray P, Gargett CE, Hapangama DK. SSEA-1 isolates human endometrial basal glandular epithelial cells: phenotypic and functional characterization and implications in the pathogenesis of endometriosis. Human Reproduction. 2013;28(10):2695-2708. https://doi.org/10.1093/humrep/det285
  15. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003-1007. https://doi.org/10.1038/nature06196
  16. Gil-Sanchis C, Cervelló I, Mas A, Faus A, Pellicer A, Simón C. Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) as a putative human endometrial stem cell marker. Molecular Human Reproduction. 2013;19(7):407-414. https://doi.org/10.1093/molehr/gat014
  17. Krusche CA, Kroll T, Beier HM, Classen-Linke I. Expression of leucine-rich repeat-containing G-protein-coupled receptors in the human cyclic endometrium. Fertility and Sterility. 2007;87(6):1428-1437. https://doi.org/10.1016/j.fertnstert.2006.11.061
  18. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell. 2002;13(12):4279-4295. https://doi.org/10.1091/mbc.E02-02-0105
  19. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Human Reproduction. 2007(11);22:2903-2911. https://doi.org/10.1093/humrep/dem265
  20. Gargett CE, Schwab KE, Zillwood RM, Nguyen HP, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biology of Reproduction. 2009;80(6):1136-1145. https://doi.org/10.1095/biolreprod.108.075226
  21. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Péault B. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008;3(3):301-313. https://doi.org/10.1016/j.stem.2008.07.003
  22. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317. https://doi.org/10.1080/14653240600855905
  23. Cervelló I, Gil-Sanchis C, Mas A, Faus A, Sanz J, Moscardó F, Higueras G, Sanz MA, Pellicer A, Simón C. Bone marrow-derived cells from male donors do not contribute to the endometrial side population of the recipient. Public Library of Science ONE. 2012; 7:30260. https://doi.org/10.1371/journal.pone.0030260
  24. Miernik K, Karasinski J. Porcine uterus contains a population of mesenchymal stem cells. Reproduction. 2012;143:203-209. https://doi.org/10.1530/REP-11-0202
  25. Masuda H, Anwar SS, Bühring HJ, Rao JR, Gargett CE. A novel marker of human endometrial mesenchymal stem-like cells. Cell Transplantation. 2012;21(10):2201-2214. https://doi.org/10.3727/096368911X637362
  26. Ulrich D, Tan K.S, Deane J, Schwab K, Cheong A, Rosamilia A, Gargett CE. Mesenchymal stem/stromal cells in post-menopausal endometrium. Human Reproduction. 2014;29(9):1895-1905. https://doi.org/10.1093/humrep/deu159
  27. Wolff EF, Wolff AB, Hongling D, Taylor HS. Demonstration of multipotent stem cells in the adult human endometrium by in vitro chondrogenesis. Reproductive Sciences. 2007;14(6):524-533. https://doi.org/10.1177/1933719107306896
  28. Dimitrov R, Timeva T, Kyurkchiev D, Stamenova M, Shterev A, Kostova P, Zlatkov V, Kehayov I, Kyurkchiev S. Characterization of clonogenic stromal cells isolated from human endometrium. Reproduction. 2008;135:551-558. https://doi.org/10.1530/REP-07-0428
  29. Gargett CE, Masuda H. Adult stem cells in the endometrium. Molecular Human Reproduction. 2010;16:818-834. https://doi.org/10.1093/molehr/gaq061
  30. Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014;32:1408-1419. https://doi.org/10.1002/stem.1681
  31. Schüring AN, Schulte N, Kelsch R, Röpke A, Kiesel L, Götte M. Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics. Fertility and Sterility. 2011;95:423-426. https://doi.org/10.1016/j.fertnstert.2010.08.035
  32. Spitzer TL, Rojas A, Zelenko Z, Aghajanova L, Erikson DW, Barragan F, Meyer M, Tamaresis JS, Hamilton AE, Irwin JC, Giudice LC. Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype. Biology of Reproduction. 2012;86:58. https://doi.org/10.1095/biolreprod.111.095885
  33. Su K, Edwards SL, Tan KS, White JF, Kandel S, Ramshaw JA, Gargett CE, Werkmeister JA. Induction of endometrial mesenchymal stem cells into tissue-forming cells suitable for fascial repair. Acta Biomaterialia. 2014;10(12):5012-5020. https://doi.org/10.1016/j.actbio.2014.08.031
  34. Ebrahimi-Barough S, Kouchesfahani HM, Ai J, Massumi M. Differentiation of human endometrial stromal cells into oligodendrocyte progenitor cells (OPCs). Journal of Molecular Neuroscience. 2013;51(2):265-273. https://doi.org/10.1007/s12031-013-9957-z
  35. Wang J, Chen S, Zhang C, Stegeman S, Pfaff-Amesse T, Zhang Y, Zhang W, Amesse L, Chen Y. Human endometrial stromal stem cells differentiate into megakaryocytes with the ability to produce functional platelets. Public Library of Science. 2012;7(8):e44300. https://doi.org/10.1371/journal.pone.0044300
  36. Koks CA, Groothuis PG, Dunselman GA, de Goeij AF, Evers JL. Adhesion of shed menstrual tissue in an in vitro model using amnion and peritoneum: a light and electron microscopic study. Human Reproduction. 1999;14(3):816-822.
  37. Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J, Wang H, Ge W, Bogin V, Chan KW, Thébaud B, Riordan NH. Endometrial regenerative cells: a novel stem cell population. Journal of Translational Medicine. 2007;5:57. https://doi.org/10.1186/1479-5876-5-57
  38. Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplantation. 2008;17:303-311.
  39. Rossignoli F, Caselli A, Grisendi G, Piccinno S, Burns JS, Murgia A, Veronesi E, Loschi P, Masini C, Conte P, Paolucci P, Horwiz EM, Dominici M. Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood. BioMed Research International. 2013;2013:901821. https://doi.org/10.1155/2013/901821
  40. Wu X, Luo Y, Chen J, Pan R, Xiang B, Du X, Xiang L, Shao J, Xiang C. Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice. Stem Cells and Development. 2014;23:1245-1257. https://doi.org/10.1089/scd.2013.0390
  41. Khoury M, Alcayaga-Miranda F, Illanes SE, Figueroa FE. The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy. Frontiers in Immunology. 2014;5:205. https://doi.org/10.3389/fimmu.2014.00205
  42. Musina RA, Belyavski AV, Tarusova OV, Solovyova EV, Sukhikh GT. Endometrial mesenchymal stem cells isolated from the menstrual blood. Bulletin of Experimental Biology and Medicine. 2008;145(4):539-543.
  43. Cui CH, Uyama T, Miyado K, Terai M, Kyo S, Kiyono T, Umezawa A. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Molecular Biology of the Cell. 2007;18(5):1586-1594. https://doi.org/10.1091/mbc.E06-09-0872
  44. Hida N, Nishiyama N, Miyoshi S, Kira S, Segawa K, Uyama T, Mori T, Miyado K, Ikegami Y, Cui C, Kiyono T, Kyo S, Shimizu T, Okano T, Sakamoto M, Ogawa S, Umezawa A. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells. 2008;26(7):1695-1704. https://doi.org/10.1634/stemcells.2007-0826
  45. Masuda H, Maruyama T, Hiratsu E, Yamane J, Iwanami A, Nagashima T, Ono M, Miyoshi H, Okano HJ, Ito M, Tamaoki N, Nomura T, Okano H, Matsuzaki Y, Yoshimura Y. Noninvasive and real-time assessment of reconstructed functional human endometrium in NOD/SCID/gamma c(null) immunodeficient mice. Proceedings of the National Academy of Sciences. 2007;104(6):1925-1930. https://doi.org/10.1073/pnas.0604310104
  46. Santamaria X, Cabanillas S, Ctrvello I, Arbona C, Raga F, Ferro J, Palmero J, Remohi J, Pellicer A, Simon C. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Human Reproduction. 2016;31(5):1087-1096. https://doi.org/10.1093/humrep/dew042
  47. Ventolini G, Zhang M, Gruber J. Hysteroscopy in the evaluation of patients with recurrent pregnancy loss: a cohort study in a primary care population. Surgical Endoscopy. 2004;18(12):1782-1784. https://doi.org/10.1007/s00464-003-8258-y
  48. Domnina AP, Fridlyanskaya II, Zemelko VI, Pugovkina NA, Kovaleva ZV, Zenin VV, Grinchuk TM, Nikolsky NN. Possibilities of cell therapy in the treatment of Asherman’s syndrome. Tsitologiya. 2013;55(1):69-74. (In Russ.)
  49. Alawadhi F, Du H, Cakmak H, Taylor HS. Bone marrow-derived stem cell (BMDSC) transplantation improves fertility in a murine model of Asherman’s syndrome. Public Library of Science ONE. 2014;9:96662. https://doi.org/10.1371/journal.pone.0096662
  50. Kilic S, Yuksel B, Pinarli F, Albayrak A, Boztok B, Delibasi T. Effect of stem cell application on Asherman syndrome, an experimental rat model. Journal of Assisted Reproduction and Genetics. 2014;31(8):975-982. https://doi.org/10.1007/s10815-014-0268-2
  51. Sugawara E, Hamatani O, Yamada Ì, Ogawa S, Kamijo S, Kuji N. Derivation of human decidua-like cells from amnion and menstrual blood. Scientific Reports. 2014;4(2):40-49. https://doi.org/10.1038/srep04599
  52. Usoltseva EO, Gzgzyan AM, Dzhemlikhanova LKh, Niauri DA. Perspectives of the clinical use of stem cells endometrial origin. Zhurnal akusherstva i zhenskikh boleznej. 2015;16(6):68-77. (In Russ.)
  53. Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman’s syndrome. Journal of Human Reproductive Sciences. 2011;4(1):43-48. https://doi.org/10.4103/0974-1208.82360
  54. Singh N, Mohanty S, Seth T, Shankar M, Bhaskaran S, Dharmendra S. Autologous stem cell transplantation in refractory Asherman’s syndrome: A novel cell based therapy. Journal of Human Reproductive Sciences. 2014;7(2):93-98. https://doi.org/10.4103/0974-1208.82360
  55. Santamaria X, Cabanillas S, Ctrvello I, Arbona C, Raga F, Ferro J, Palmero J, Remohi J, Pellicer A, Simon C. Autologous cell therapy with CD133+ bone marrow-derived stev cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Human Reproduction. 2016;31(5):1087-1096. https://doi.org/10.1093/humrep/dew042
  56. Liu T, Huang Y, Zhang J, Qin W, Chi H, Chen J, Yu Z, Chen C. Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model. Stem Cells and Development. 2014;23(13):1548-1557. https://doi.org/10.1089/scd.2013.0371
  57. Gargett CE, Healy DL. Generating receptive endometrium in Asherman’s syndrome. Journal of Human Reproductive Sciences. 2011;4(1):49-52.
  58. Park JH, Daheron L, Kantarci S, Lee BS, Teixeira JM. Human endometrial cells express elevated levels of pluripotent factors and are more amenable to reprogramming into induced pluripotent stem cells. Endocrinology. 2011;152:1080-1089. https://doi.org/10.1210/en.2010-1072
  59. De Carvalho Rodrigues D, Asensi KD, Vairo L, Azevedo-Pereira RL, Silva R, Rondinelli E, Goldenberg RC, Campos de Carvalho AC, Urményi TP. Human menstrual blood-derived mesenchymal cells as a cell source of rapid and efficient nuclear reprogramming. Cell Transplantation. 2012;21(10):2215-2224. https://doi.org/10.3727/096368912X653048
  60. Li Y, Li X, Zhao H, Feng R, Zhang X, Tai D, An G, Wen J, Tan J. Efficient induction of pluripotent stem cells from menstrual blood. Stem Cells and Development. 2013;22(7):1147-1158. https://doi.org/10.1089/scd.2012.0428
  61. Eaker S, Armant M, Brandwein H, Burger S, Campbell A, Carpenito C, Clarke D, Fong T, Karnieli O, Niss K, Van’t Hof W, Wagey R. Concise review: guidance in developing commercializable autologous/patient-specific cell therapy manufacturing. Stem Cells Translational Medicine. 2013;2(11):871-883. https://doi.org/10.5966/sctm.2013-0050
  62. Hunsberger J, Harrysson O, Shirwaiker R, Starly B, Wysk R, Cohen P, Allickson J, Yoo J, Atala A. Manufacturing road map for tissue engineering and regenerative medicine technologies. Stem Cells Translational Medicine. 2015;4(2):130-135. https://doi.org/10.5966/sctm.2014-0254
  63. Rajaraman G, White J, Tan KS, Ulrich D, Rosamilia A, Werkmeister J, Gargett CE. Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application. Tissue Engineering Part C: Methods. 2013;19(1):80-92. https://doi.org/10.1089/ten.TEC.2011.0718
  64. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nature Reviews Immunology. 2012;12(5):383-396. https://doi.org/10.1038/nri3209
  65. Bianco P, Cao X, Frenette PS, Mao JJ, Robey PG, Simmons PJ, Wang CY. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nature Medicine. 2013;19(1):35-42. https://doi.org/10.1038/nm.3028
  66. Krampera M. Mesenchymal stromal cell «licensing»: a multistep process. Leukemia. 2011;25(9):1408-1414. https://doi.org/10.1038/leu.2011.108

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.